Hap Trading, LLC Marker Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 11,300 shares of MRKR stock, worth $22,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,300Holding current value
$22,035% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRKR
# of Institutions
5Shares Held
475KCall Options Held
0Put Options Held
0-
Act Capital Management, LLC Wayne, PA354KShares$691,0800.18% of portfolio
-
Ar Asset Management Inc73.7KShares$143,7150.05% of portfolio
-
Personal Capital Advisors Corp25.7KShares$50,1380.0% of portfolio
-
American Portfolios Advisors Holbrook, NY21.2KShares$41,2810.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $163M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...